Cargando…

Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care

SIMPLE SUMMARY: Historically, patients with pancreatic ductal adenoma carcinoma were subjected to immediate surgical resection of the pancreatic tumor. Nowadays, more and more patients are treated with chemo(radio)therapy before surgical resection. It is known that patients with pancreatic cancer ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Willems, R. A. L., Michiels, N., Lanting, V. R., Bouwense, S., van den Broek, B. L. J., Graus, M., Klok, F. A., Groot Koerkamp, B., de Laat, B., Roest, M., Wilmink, J. W., van Es, N., Mieog, J. S. D., ten Cate, H., de Vos-Geelen, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376958/
https://www.ncbi.nlm.nih.gov/pubmed/37509209
http://dx.doi.org/10.3390/cancers15143546
_version_ 1785079397959598080
author Willems, R. A. L.
Michiels, N.
Lanting, V. R.
Bouwense, S.
van den Broek, B. L. J.
Graus, M.
Klok, F. A.
Groot Koerkamp, B.
de Laat, B.
Roest, M.
Wilmink, J. W.
van Es, N.
Mieog, J. S. D.
ten Cate, H.
de Vos-Geelen, J.
author_facet Willems, R. A. L.
Michiels, N.
Lanting, V. R.
Bouwense, S.
van den Broek, B. L. J.
Graus, M.
Klok, F. A.
Groot Koerkamp, B.
de Laat, B.
Roest, M.
Wilmink, J. W.
van Es, N.
Mieog, J. S. D.
ten Cate, H.
de Vos-Geelen, J.
author_sort Willems, R. A. L.
collection PubMed
description SIMPLE SUMMARY: Historically, patients with pancreatic ductal adenoma carcinoma were subjected to immediate surgical resection of the pancreatic tumor. Nowadays, more and more patients are treated with chemo(radio)therapy before surgical resection. It is known that patients with pancreatic cancer have a high risk of developing thrombosis. However, as patients underwent immediate surgery before, the incidence of thrombosis in patients with pancreatic cancer during neoadjuvant chemotherapy is understudied. Few studies have investigated the VTE incidence in this population and it is unclear whether these patients should use perioperative thromboprophylaxis to prevent thrombosis. This narrative review summarizes the evidence that is currently available. ABSTRACT: Recent studies have shown that patients with pancreatic ductal adenocarcinoma (PDAC) treated with neoadjuvant chemo(radio)therapy followed by surgery have an improved outcome compared to patients treated with upfront surgery. Hence, patients with PDAC are more and more frequently treated with chemotherapy in the neoadjuvant setting. PDAC patients are at a high risk of developing venous thromboembolism (VTE), which is associated with decreased survival rates. As patients with PDAC were historically offered immediate surgical resection, data on VTE incidence and associated preoperative risk factors are scarce. Current guidelines recommend primary prophylactic anticoagulation in selected groups of patients with advanced PDAC. However, recommendations for patients with (borderline) resectable PDAC treated with chemotherapy in the neoadjuvant setting are lacking. Nevertheless, the prevention of complications is crucial to maintain the best possible condition for surgery. This narrative review summarizes current literature on VTE incidence, associated risk factors, risk assessment tools, and primary thromboprophylaxis in PDAC patients treated with neoadjuvant chemo(radio)therapy.
format Online
Article
Text
id pubmed-10376958
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103769582023-07-29 Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care Willems, R. A. L. Michiels, N. Lanting, V. R. Bouwense, S. van den Broek, B. L. J. Graus, M. Klok, F. A. Groot Koerkamp, B. de Laat, B. Roest, M. Wilmink, J. W. van Es, N. Mieog, J. S. D. ten Cate, H. de Vos-Geelen, J. Cancers (Basel) Review SIMPLE SUMMARY: Historically, patients with pancreatic ductal adenoma carcinoma were subjected to immediate surgical resection of the pancreatic tumor. Nowadays, more and more patients are treated with chemo(radio)therapy before surgical resection. It is known that patients with pancreatic cancer have a high risk of developing thrombosis. However, as patients underwent immediate surgery before, the incidence of thrombosis in patients with pancreatic cancer during neoadjuvant chemotherapy is understudied. Few studies have investigated the VTE incidence in this population and it is unclear whether these patients should use perioperative thromboprophylaxis to prevent thrombosis. This narrative review summarizes the evidence that is currently available. ABSTRACT: Recent studies have shown that patients with pancreatic ductal adenocarcinoma (PDAC) treated with neoadjuvant chemo(radio)therapy followed by surgery have an improved outcome compared to patients treated with upfront surgery. Hence, patients with PDAC are more and more frequently treated with chemotherapy in the neoadjuvant setting. PDAC patients are at a high risk of developing venous thromboembolism (VTE), which is associated with decreased survival rates. As patients with PDAC were historically offered immediate surgical resection, data on VTE incidence and associated preoperative risk factors are scarce. Current guidelines recommend primary prophylactic anticoagulation in selected groups of patients with advanced PDAC. However, recommendations for patients with (borderline) resectable PDAC treated with chemotherapy in the neoadjuvant setting are lacking. Nevertheless, the prevention of complications is crucial to maintain the best possible condition for surgery. This narrative review summarizes current literature on VTE incidence, associated risk factors, risk assessment tools, and primary thromboprophylaxis in PDAC patients treated with neoadjuvant chemo(radio)therapy. MDPI 2023-07-08 /pmc/articles/PMC10376958/ /pubmed/37509209 http://dx.doi.org/10.3390/cancers15143546 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Willems, R. A. L.
Michiels, N.
Lanting, V. R.
Bouwense, S.
van den Broek, B. L. J.
Graus, M.
Klok, F. A.
Groot Koerkamp, B.
de Laat, B.
Roest, M.
Wilmink, J. W.
van Es, N.
Mieog, J. S. D.
ten Cate, H.
de Vos-Geelen, J.
Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care
title Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care
title_full Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care
title_fullStr Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care
title_full_unstemmed Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care
title_short Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care
title_sort venous thromboembolism and primary thromboprophylaxis in perioperative pancreatic cancer care
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376958/
https://www.ncbi.nlm.nih.gov/pubmed/37509209
http://dx.doi.org/10.3390/cancers15143546
work_keys_str_mv AT willemsral venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare
AT michielsn venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare
AT lantingvr venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare
AT bouwenses venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare
AT vandenbroekblj venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare
AT grausm venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare
AT klokfa venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare
AT grootkoerkampb venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare
AT delaatb venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare
AT roestm venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare
AT wilminkjw venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare
AT vanesn venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare
AT mieogjsd venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare
AT tencateh venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare
AT devosgeelenj venousthromboembolismandprimarythromboprophylaxisinperioperativepancreaticcancercare